drugset / Trial / NCT01562548

Exploratory Efficacy Study of Guaifenesin in Upper Back Pain

NCT01562548 ↗

Completed 78 enrolled GlaxoSmithKline
RandomizedSingle-groupSingle-blindTreatment

Summary

Explore the clinical efficacy of 7-day treatment regimens of guaifenesin in order to investigate the evidence that guaifenesin is an effective treatment for upper back/neck/shoulder muscle spasm/stiffness and pain.

Timeline

Start
2012-02
Primary completion
2013-05
Completion
2013-05

Outcome

Missed primary endpoint

registry Guaifenesin 600mg vs Placebo Matching Guaifenesin 600mg; p = 0.68 NCT01562548 ↗

registry Guaifenesin 1200mg vs Placebo Matching Guaifenesin 1200mg; p = 0.52 NCT01562548 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaifenesin Small molecule — —

Indications

No indication recorded.